Classify cancers differently to improve access to treatments. New anticancer drugs often target molecular specificities carried by cancers located on a wide variety of organs.
Better treating the disease will involve reviewing the way it has been understood until now. We generally understand cancer based on where it started. But in recent decades, certain tumors observed in very different organs are characterized by very similar anomalies and/or mechanisms. This has made this organ typology partly obsolete. It would allow better accessibility to cancer treatment.